SG10201403703XA - Methods of producing humanized non-human mammals - Google Patents

Methods of producing humanized non-human mammals

Info

Publication number
SG10201403703XA
SG10201403703XA SG10201403703XA SG10201403703XA SG10201403703XA SG 10201403703X A SG10201403703X A SG 10201403703XA SG 10201403703X A SG10201403703X A SG 10201403703XA SG 10201403703X A SG10201403703X A SG 10201403703XA SG 10201403703X A SG10201403703X A SG 10201403703XA
Authority
SG
Singapore
Prior art keywords
methods
human mammals
producing humanized
humanized non
producing
Prior art date
Application number
SG10201403703XA
Other languages
English (en)
Inventor
Qingfeng Chen
Jianzhu Chen
Original Assignee
Qingfeng Chen
Jianzhu Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingfeng Chen, Jianzhu Chen filed Critical Qingfeng Chen
Publication of SG10201403703XA publication Critical patent/SG10201403703XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2893—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0381—Animal model for diseases of the hematopoietic system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG10201403703XA 2009-06-29 2010-06-28 Methods of producing humanized non-human mammals SG10201403703XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22143809P 2009-06-29 2009-06-29

Publications (1)

Publication Number Publication Date
SG10201403703XA true SG10201403703XA (en) 2014-10-30

Family

ID=43411395

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201403703XA SG10201403703XA (en) 2009-06-29 2010-06-28 Methods of producing humanized non-human mammals
SG2011084647A SG176118A1 (en) 2009-06-29 2010-06-28 Methods of producing humanized non-human mammals

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2011084647A SG176118A1 (en) 2009-06-29 2010-06-28 Methods of producing humanized non-human mammals

Country Status (6)

Country Link
US (1) US20120157667A1 (cg-RX-API-DMAC7.html)
EP (1) EP2449094A4 (cg-RX-API-DMAC7.html)
JP (1) JP2012531896A (cg-RX-API-DMAC7.html)
CN (1) CN102725400A (cg-RX-API-DMAC7.html)
SG (2) SG10201403703XA (cg-RX-API-DMAC7.html)
WO (1) WO2011002727A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4502152A3 (en) 2009-10-06 2025-04-30 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
PT4233537T (pt) 2011-02-15 2025-09-08 Regeneron Pharma Ratinhos humanizados para m-csf e utilizações dos mesmos
WO2013086019A1 (en) * 2011-12-06 2013-06-13 Massachusetts Institute Of Technology Use of humanized mice to determine toxicity
CN103387955B (zh) * 2012-05-10 2015-04-29 上海南方模式生物科技发展有限公司 非人哺乳动物b淋巴细胞缺陷动物模型的制备方法及其用途
WO2014039733A1 (en) * 2012-09-05 2014-03-13 University Of Southern California Methods and compositions for detecting, imaging, and treating small cell lung cancer utilizing post-translationally modified residues and higher molecular weight antigenic complexes in proteins
KR102241962B1 (ko) * 2012-09-07 2021-04-20 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
DK4389764T3 (da) * 2012-11-05 2026-04-13 Regeneron Pharma Genetisk modificerede gnavere og fremgangsmåder til anvendelse heraf
WO2014121840A1 (en) * 2013-02-07 2014-08-14 Medizinische Hochschule Hannover Induced dendritic cells and uses thereof
WO2014196929A1 (en) * 2013-06-05 2014-12-11 Agency For Science, Technology And Research A humanized mouse model for study of bona fide hepatitis virus infection and use thereof
NO2785538T3 (cg-RX-API-DMAC7.html) * 2014-05-07 2018-08-04
EP3482629B1 (en) * 2014-05-19 2020-11-25 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals expressing human epo
ES2950399T3 (es) 2015-04-13 2023-10-09 Regeneron Pharma Ratones humanizados Sirpa-IL15 insertados y métodos de uso de los mismos
JP6654001B2 (ja) * 2015-05-27 2020-02-26 公益財団法人実験動物中央研究所 ヒトil−15分泌免疫不全マウス
EP3383173B1 (en) * 2015-11-30 2020-11-25 H. Hoffnabb-La Roche Ag Generation of human macrophages in immunodeficient mice
US20200315147A1 (en) * 2017-11-17 2020-10-08 University Of Tsukuba Non-human animal and method for producing same
CN111304248B (zh) 2018-12-25 2021-08-24 百奥赛图江苏基因生物技术有限公司 人源化细胞因子il15基因改造非人动物的构建方法及应用
CN111172190B (zh) * 2018-12-25 2021-07-30 百奥赛图江苏基因生物技术有限公司 人源化细胞因子csf2基因改造非人动物的构建方法及应用
WO2020157997A1 (ja) * 2019-01-28 2020-08-06 公益財団法人実験動物中央研究所 ヒトil-34を有する非ヒト動物及びその使用
CN113677199A (zh) * 2019-02-13 2021-11-19 杰克逊实验室 支持先天免疫功能的转基因小鼠模型
US20220192166A1 (en) * 2019-03-28 2022-06-23 Central Institute For Experimental Animals Immunodeficient rodent
CN111485001A (zh) * 2020-04-14 2020-08-04 澎立生物医药技术(上海)有限公司 具有nk细胞及adcc能力的人源化免疫系统小鼠的构建方法
US20230340524A1 (en) * 2020-07-08 2023-10-26 The Jackson Laboratory Transgenic mouse models supporting human innate immune function
CN112042597B (zh) * 2020-07-22 2022-04-29 南京普恩瑞生物科技有限公司 一种双人源化肿瘤异种移植模型的构建方法
CN114853871B (zh) * 2021-04-20 2024-04-05 百奥赛图(北京)医药科技股份有限公司 Csf1和/或csf1r基因人源化的非人动物及其构建方法和应用
CN117070524A (zh) * 2022-08-15 2023-11-17 江苏集萃药康生物科技股份有限公司 一种白介素人源化的非人动物的制备方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3853201T2 (de) * 1987-12-23 1995-09-14 Univ Leland Stanford Junior Schimäre immunkompromittierende Säugetiere und ihre Verwendung.
US5639939A (en) * 1987-12-23 1997-06-17 The Board Of Trustees For The Leland Stanford Junior University Chimeric immunocompromised mammal comprosing vascularized fetal organ tissue
JPH09506626A (ja) * 1993-12-17 1997-06-30 システミクス・インコーポレイテッド 非自己造血細胞移植片の生存延長のためのマクロファージ枯渇剤の使用および動物モデル検定系
US6015554A (en) * 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
US6060643A (en) * 1995-08-04 2000-05-09 Emory University Mouse model with human immune system
US20070021364A1 (en) * 1995-12-13 2007-01-25 Hans Herweijer Methods for genetic immunization
WO1999061589A2 (en) * 1998-05-28 1999-12-02 St. Jude Children's Research Hospital Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
AU4323599A (en) * 1998-05-29 1999-12-13 Instituto Superiore Di Sanita Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
JP2006501177A (ja) * 2002-06-24 2006-01-12 ジェンザイム・コーポレイション 遺伝子治療薬を送達する方法
GB0406728D0 (en) * 2004-03-25 2004-04-28 Hydrodynamic Gene Delivery Ltd Gene therapy
US8252587B2 (en) * 2004-10-25 2012-08-28 Celerant Therapeutics, Inc. Methods of expanding myeloid cell populations and uses thereof
AU2007238660C1 (en) * 2006-04-14 2013-11-07 Astellas Institute For Regenerative Medicine Hemangio-colony forming cells
CA2680613A1 (en) * 2007-03-13 2008-09-18 National Jewish Medical And Research Center Methods for generation of antibodies
CA2636876A1 (en) * 2008-02-25 2009-08-25 Gestion Univalor Inc. Methods and kits for expanding hematopoietic stem cells
WO2010115115A1 (en) * 2009-04-03 2010-10-07 Inserm ( Institut National De La Sante Et De La Recherche) Dendritic cell-boosted humanized immune system mice
SG10201403707QA (en) * 2009-06-29 2014-10-30 Ilya B Leskov Non-human mammal model of human hematopoietic cancer
EP4502152A3 (en) * 2009-10-06 2025-04-30 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment

Also Published As

Publication number Publication date
WO2011002727A1 (en) 2011-01-06
EP2449094A4 (en) 2013-07-10
EP2449094A1 (en) 2012-05-09
JP2012531896A (ja) 2012-12-13
WO2011002727A9 (en) 2011-02-24
US20120157667A1 (en) 2012-06-21
SG176118A1 (en) 2011-12-29
CN102725400A (zh) 2012-10-10

Similar Documents

Publication Publication Date Title
EP2449094A4 (en) METHOD FOR PRODUCING HUMANIZED NON-MAMMAL MAMMALS
ZA201009312B (en) Antibody producing non-human mammals
IL229117A0 (en) A process for the production of a phenylacetamide compound
IL217381A0 (en) Optimizing the production of antibodies
EP2646879A4 (en) PROCESS FOR PREPARING A TONER
IL248217B (en) A method for the production of inganol-3-englate
IL217919A0 (en) Humanized anti-cdcp1 antibodies
PT2760619T (pt) Método para produzir uma estrutura
HUE052073T2 (hu) Eljárás foszgén elõállítására
IL216894A0 (en) Method of producing advanced composite components
GB2469158B (en) Base-assisted formation of tin-sucrose adducts
PL2432877T3 (pl) Metoda otrzymywania (+) -zizaenu
GB2465047B (en) Prediction of signals
IL214287A0 (en) Method for producing 2-aminobiphenylene
HRP20130605T1 (en) Method for producing die-cast parts
IL216694A0 (en) Method for producing fluoroalkyl nitriles
GB201017392D0 (en) Method for producing L-fucose
EP2420492A4 (en) PROCESS FOR PREPARING 2-HALOGEN-6-SUBSTITUTED 4-TRIFLUOROMETHYLPYRIDINE
PL386122A1 (pl) Sposób wytwarzania styropianu o podwyższonej izolacyjności termicznej
TWM365675U (en) Improved structure of teapoy
GB0900522D0 (en) Method of producing archtectural moulding
PL387300A1 (pl) Sposób wytwarzania oligowęglanodioli z węglanu dimetylu
GB0909872D0 (en) Method of producing presentations
GB0902151D0 (en) method of fabricating an object
PL389965A1 (pl) Sposób wytwarzania 3ß - hydroksy-17 a-oxa-D-homo-5α-androst-17-onu